Skip to main content
SpringerLink
Log in

Prescription digital therapeutic, reSET-O, saves costs in US patients with opioid use disorder

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The study was published by Pear Therapeutics.

Reference

  • Velez FF, et al. Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder ClinicoEconomics and Outcomes Research : 29 Oct 2021. Available from: URL: https://doi.org/10.2147/CEOR.S334274

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prescription digital therapeutic, reSET-O, saves costs in US patients with opioid use disorder. PharmacoEcon Outcomes News 891, 22 (2021). https://doi.org/10.1007/s40274-021-08180-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08180-7

Search

Navigation